These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24131915)

  • 21. Endothelin receptor antagonism and renin inhibition as treatment options for scleroderma kidney.
    Dhaun N; MacIntyre IM; Bellamy CO; Kluth DC
    Am J Kidney Dis; 2009 Oct; 54(4):726-31. PubMed ID: 19376621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Raynaud, digital ulcers and calcinosis in scleroderma.
    Nitsche A
    Reumatol Clin; 2012; 8(5):270-7. PubMed ID: 22835924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bosentan for digital ulcers prevention does not worsen cardiopulmonary exercise test parameters in SSc patients with interstitial lung disease.
    Romaniello A; Gigante A; Di Paolo M; Tallerini G; Barbano B; Amoroso D; Palange P; Rosato E
    Int J Cardiol; 2016 Nov; 223():113-115. PubMed ID: 27537734
    [No Abstract]   [Full Text] [Related]  

  • 24. [Ischemic ulcers in systemic connective tissue disorders].
    Gran JT; Midtvedt Ø
    Tidsskr Nor Laegeforen; 2006 Nov; 126(23):3089-92. PubMed ID: 17160111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A clinical comparison of an endothelin receptor antagonist and phosphodiesterase type 5 inhibitors for treating digital ulcers of systemic sclerosis.
    Chang SH; Jun JB; Lee YJ; Kang TY; Moon KW; Ju JH; Kang SW; Choi IA; Park YB; Lee SG; Lee SS; Heo NH; Lee EB
    Rheumatology (Oxford); 2021 Dec; 60(12):5814-5819. PubMed ID: 33576774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Management of digital ulcers from systemic scleroderma].
    Francès C; Allanore Y; Cabane J; Carpentier P; Dumontier C; Hachulla E; Hatron PY; Lipsker D; Meaume S; Mouthon L; Senet P; Sibilia J;
    Presse Med; 2008 Feb; 37(2 Pt 2):271-85. PubMed ID: 18031977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan.
    Sebastiani M; Manfredi A; Cestelli V; Praino E; Cannarile F; Giuggioli D; Colaci M; Ferri C
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S196. PubMed ID: 26242501
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of digital ulcers in systemic sclerosis: Case series study of thirteen patients and discussion on outcome.
    Abuowda Y; Almeida RS; Oliveira AA; Pego P; Santos C; Matos-Costa J
    Rev Assoc Med Bras (1992); 2017 May; 63(5):422-426. PubMed ID: 28724039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of botulinum toxin injection on systemic sclerosis-related digital ulcers.
    Souk JW; Kim HS
    Korean J Intern Med; 2019 Sep; 34(5):1169-1170. PubMed ID: 30099864
    [No Abstract]   [Full Text] [Related]  

  • 30. Oral sildenafil in skin ulcers secondary to systemic sclerosis.
    Della Rossa A; Doveri M; D'Ascanio A; Tavoni A; Consensi A; Neri R; Bazzichi L; Bombardieri S
    Scand J Rheumatol; 2011; 40(4):323-5. PubMed ID: 21639825
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of digital ulcers in systemic sclerosis: recent developments and future perspectives.
    Sagonas I; Daoussis D
    Clin Rheumatol; 2023 Oct; 42(10):2589-2599. PubMed ID: 36847929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New hope for systemic sclerosis patients with digital ulcers.
    Varga J
    Curr Rheumatol Rep; 2005 Apr; 7(2):127-8. PubMed ID: 15760591
    [No Abstract]   [Full Text] [Related]  

  • 33. [Digital ulcers in systemic sclerosis].
    Prus V
    Reumatizam; 2010; 57(2):115-7. PubMed ID: 21875016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Digital ulcers in systemic sclerosis.
    Hughes M; Herrick AL
    Rheumatology (Oxford); 2017 Jan; 56(1):14-25. PubMed ID: 27094599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.
    Korn JH; Mayes M; Matucci Cerinic M; Rainisio M; Pope J; Hachulla E; Rich E; Carpentier P; Molitor J; Seibold JR; Hsu V; Guillevin L; Chatterjee S; Peter HH; Coppock J; Herrick A; Merkel PA; Simms R; Denton CP; Furst D; Nguyen N; Gaitonde M; Black C
    Arthritis Rheum; 2004 Dec; 50(12):3985-93. PubMed ID: 15593188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Bosentan in the Treatment of Digital Ulcers in Korean Patients With Systemic Sclerosis: A Longitudinal, Multicenter, Uncontrolled Trial.
    Lee KA; Park S; Kim BY; Kim YS; Ju JH; Son CN; Kim SH; Kim HS
    J Clin Rheumatol; 2021 Dec; 27(8):e599-e601. PubMed ID: 33448749
    [No Abstract]   [Full Text] [Related]  

  • 37. Differences in disability as measured by the Health Assessment Questionnaire between patients with and without digital ulcers in systemic sclerosis: a post hoc analysis of pooled data from two randomised controlled trials in digital ulcers using bosentan.
    Zelenietz C; Pope J
    Ann Rheum Dis; 2010 Nov; 69(11):2055-6. PubMed ID: 20959328
    [No Abstract]   [Full Text] [Related]  

  • 38. [Updated treatment of primary pulmonary hypertension -- the role of endothelin receptor antagonists].
    Callejas Rubio JL; Ortego Centeno N; Navarro Pelayo F; Vallejo Rodríguez I
    Farm Hosp; 2004; 28(4):294-5. PubMed ID: 15369441
    [No Abstract]   [Full Text] [Related]  

  • 39. Digital ulcers: overt vascular disease in systemic sclerosis.
    Steen V; Denton CP; Pope JE; Matucci-Cerinic M
    Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii19-24. PubMed ID: 19487218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Digital ulcers and outcomes assessment in scleroderma.
    Matucci-Cerinic M; Seibold JR
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v46-7. PubMed ID: 18784143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.